ARIUS PHARMACEUTICALS
Arius Pharmaceuticals is a healthcare company that operates as a specialty pharmaceutical company which develops and commercializes supportive care prescription products for the treatment of acute conditions common to surgical and cancer patients, such as pain, nausea, and vomiting. The company was founded in 2003 by Mark A. Sirgo and Andrew L. Finn and it is located in the United States.
ARIUS PHARMACEUTICALS
Industry:
Health Care
Address:
Morrisville, North Carolina, United States
Country:
United States
Status:
Active
Similar Organizations
Ansan Pharmaceuticals
Ansan Pharmaceuticals is a Health Care company.
Aryx Pharmaceuticals
Aryx Pharmaceuticals is a Health Care company.
MedPointe Pharmaceuticals
MedPointe Pharmaceuticals is a Health Care company.
Founder
More informations about "Arius Pharmaceuticals"
Arius Pharmaceuticals - Crunchbase Company Profile & Funding
Arius Pharmaceuticals is a healthcare company that operates as a specialty pharmaceutical company which develops and commercializes supportive care prescription products for the …See details»
Leadership - Kisoji Biotechnology Inc.
Previously, he was the founder, C.S.O. and C.E.O. of ARIUS Research Inc., a publicly-traded biotechnology company developing therapeutic cancer antibodies and sold to Roche in 2008. …See details»
Toronto-based Arius scores big (and a win for investors)
Sep 29, 2008 I lucked out last week: I happened to be sitting next to David Young during a pharmaceutical industry business function. David is a Founder and CEO of Arius Research …See details»
Lee Babiss, Head of Global Research at Roche. “T
Roche and ARIUS Research Inc. today announced that the two companies have signed a definitive agreement for Roche to acquire ARIUS in an all-cash transaction at a price of …See details»
Arius Pharmaceuticals, Inc. - VentureRadar
Arius Pharmaceuticals, Inc. VentureRadar profile. Find out more about Arius Pharmaceuticals, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Intellectual Property Assignment Agreement - SEC.gov
This Intellectual Property Assignment Agreement (the Agreement ) is made as of September 5, 2007 (the Effective Date ) by and between QLT USA, Inc. (formerly Atrix Laboratories, Inc.), a …See details»
bdsi-20210930
Sep 30, 2021 The condensed consolidated financial statements include the accounts of the Company, Arius Pharmaceuticals, Inc. and Arius Two, Inc. All significant inter-company …See details»
Amended and Restated Clinical Development and License …
1.78 “ QLT Agreements ” mean that certain Intellectual Property Assignment Agreement, dated as of August 2, 2006, between Arius Two and QLT USA, Inc. (“QLT”), as amended, that certain …See details»
Andrew Finn - Previous Vice President for Arius Pharmaceuticals, Inc.
View Andrew L Finn's profile for company associations, background information, and partnerships. Search our database of over 100 million company and executive profiles.See details»
Organization and Personnel in Pharmaceutical Manufacturing: …
Introduction In the complex field of pharmaceutical manufacturing, it is important to have a sound quality system in place to ensure that products manufactured have the desired quality, safety, …See details»
Akur8 Expands Core Capabilities with Strategic Acquisition of Arius ...
Sep 9, 2024 Akur8 acquires Arius Akur8 expands core capabilities with strategic acquisition of Arius Reserving Solution. The Senior team from Akur8 and Arius CEO Samuel Falmagne and …See details»
Some of the Most Common Deficiencies in Recent ASC Surveys
Some of the most common deficiencies in recent surveys are directly related to medication management and safety. How does your facility oversee pharmaceutical services and patient …See details»
Arcus Biosciences | Pursuit of Cures for Cancer
Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies.See details»
Security Agreement - SEC.gov
Collateral means all of Debtor s right, title, and interest in and to the Purchased Assets, that certain BEMA License Agreement, entered into of even date herewith, between Debtor and …See details»
Using surveys for change: An applied example in a …
Leadership & organization development journal. - Bradford : Emerald, ISSN 0143-7739, ZDB-ID 4461940. - Vol. 16.1995, 4, p. 3-11 Check Google Scholar| More access options In libraries …See details»
NATIONAL SECURITY ON DRUGS AND MEDICAL SUPPLIES IN …
This research had objectives to 1 study roles and problem state of the Government Pharmaceutical Organization (GPO), 2 study the development of the GPO and 3) propose a …See details»
Maintenance Supervisor, RIDGEFIELD, Connecticut, USA | Cushman ...
Job Title Job Description Summary Job Description Essential Functions and Responsibilities Pay: $40hr-$50hr.Knowledge and experience in pharmaceutical research, development, and …See details»
Full List of Pharmaceutical Companies in Tamil Nadu, India (2024)
Jun 6, 2023 There are as many as 400 pharmaceutical companies in Tamil Nadu, a state in India. They manufacture bulk formulations, active pharmaceutical ingredients,See details»
State Drug Alert: 93 Drug samples including Glenmark's TELMA …
Mar 1, 2025 In addition, popular medicines such as TELMA AM manufactured by Glenmark Pharmaceuticals and Ondem-4 [Ondansetron Tablets IP] manufactured by Alkem Health …See details»
Organization | Pharmaceuticals and Medical Devices Agency - PMDA
Nov 1, 2024 Organization Chart Click this image to get PDF file of organization chart. (As of November 1, 2024) [141KB]See details»